Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2011, Article ID 971502, 8 pages
http://dx.doi.org/10.1155/2011/971502
Research Article

Infection of Human Coronary Artery Endothelial Cells by Group B Streptococcus Contributes to Dysregulation of Apoptosis, Hemostasis, and Innate Immune Responses

1Institute of Clinical Biochemistry and Pathobiochemistry, University of Wuerzburg, D-97080 Wuerzburg, Germany
2Medical Hospital II, University of Wuerzburg, D-97080 Wuerzburg, Germany
3University Children’s Hospital, University of Wuerzburg, D-97080 Wuerzburg, Germany
4Laboratory for Microarray Applications, University of Wuerzburg, D-97080 Wuerzburg, Germany

Received 18 August 2010; Accepted 3 January 2011

Academic Editor: Donna-Marie McCafferty

Copyright © 2011 Claudia Beyrich et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. F. Tumbaga and A. G. S. Philip, “Perinatal Group B streptococcal infections and the new guidelines,” NeoReviews, vol. 7, no. 10, pp. 524–530, 2006. View at Publisher · View at Google Scholar
  2. C. J. Baker and M. S. Edwards, “Group B streptococcal infections,” in Infectious Diseases of the Fetus and Newborn Infant, J. S. Remington, J. O. Klein, C. B. Wilson, and C. J. Baker, Eds., pp. 1091–1156, W. B. Saunders, Philadelphia, Pa, USA, 5th edition, 2001. View at Google Scholar
  3. E. Barcaite, A. Bartusevicius, R. Tameliene, M. Kliucinskas, L. Maleckiene, and R. Nadisauskiene, “Prevalence of maternal group B streptococcal colonisation in European countries,” Acta Obstetricia et Gynecologica Scandinavica, vol. 87, no. 3, pp. 260–271, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. W. Larsen and J. L. Sever, “Group B streptococcus and pregnancy: a review,” American Journal of Obstetrics and Gynecology, vol. 198, no. 4, pp. 440–450, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. D. S. McKenna and J. D. Iams, “Group B streptococcal infections,” Seminars in Perinatology, vol. 22, no. 4, pp. 267–276, 1998. View at Google Scholar · View at Scopus
  6. S. Håkansson and K. Källén, “Impact and risk factors for early-onset group B streptococcal morbidity: analysis of a national, population-based cohort in Sweden 1997–2001,” British Journal of Obstetrics and Gynaecology, vol. 113, no. 12, pp. 1452–1458, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. S. J. Schrag, S. Zywicki, M. M. Farley et al., “Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis,” New England Journal of Medicine, vol. 342, no. 1, pp. 15–20, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. M. S. Edwards, M. A. Rench, D. L. Palazzi, and C. J. Baker, “Group B streptococcal colonization and serotype-specific immunity in healthy elderly persons,” Clinical Infectious Diseases, vol. 40, no. 3, pp. 352–357, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. U. Schwarz-Linek, M. Höök, and J. R. Potts, “The molecular basis of fibronectin-mediated bacterial adherence to host cells,” Molecular Microbiology, vol. 52, no. 3, pp. 631–641, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Urlichs and C. P. Speer, “Neutrophil function in preterm and term infants,” NeoReviews, vol. 5, pp. e417–e430, 2004. View at Google Scholar
  11. S. M. Dudek, N. M. Muňoz, A. Desai, C. M. Osan, A. Y. Meliton, and A. R. Leff, “Group V phospholipase A2 mediates barrier disruption of human pulmonary endothelialcells caused by LPS in vitro,” American Journal of Respiratory Cell and Molecular Biology. In press.
  12. A. Lembo, M. A. Gurney, K. Burnside et al., “Regulation of CovR expression in Group B streptococcus impacts blood-brain barrier penetration,” Molecular Microbiology, vol. 77, no. 2, pp. 431–443, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. D. D. Bannerman and S. E. Goldblum, “Direct effects of endotoxin on the endotheliumml: barrier function and injury,” Laboratory Investigation, vol. 79, no. 10, pp. 1181–1199, 1999. View at Google Scholar · View at Scopus
  14. J. M. Silva and C. Saldanha, “Arterial endothelium and atherothrombogenesis II—the role of endothelial dysfunction in atherothrombotic lesions,” Revista Portuguesa de Cardiologia, vol. 25, no. 12, pp. 1159–1186, 2006. View at Google Scholar · View at Scopus
  15. W. Huber, A. Von Heydebreck, H. Sültmann, A. Poustka, and M. Vingron, “Variance stabilization applied to microarray data calibration and to the quantification of differential expression,” Bioinformatics, vol. 18, no. 1, pp. S96–S104, 2002. View at Google Scholar · View at Scopus
  16. J. Loeffler, P. Swatoch, D. Akhawi-Araghi, H. Hebart, and H. Einsele, “Automated RNA extraction by MagNA pure followed by rapid quantification of cytokine and chemokine gene expression with use of fluorescence resonance energy transfer,” Clinical Chemistry, vol. 49, no. 6, pp. 955–958, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. F. A. D. T. G. Wagener, H. D. Volk, D. Willis et al., “Different faces of the heme-heme oxygenase system in inflammation,” Pharmacological Reviews, vol. 55, no. 3, pp. 551–571, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Proost, C. De Wolf-Peeters, R. Conings, G. Opdenakker, A. Billiau, and J. Van Damme, “Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells: in vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8,” Journal of Immunology, vol. 150, no. 3, pp. 1000–1010, 1993. View at Google Scholar · View at Scopus
  19. A. Wuyts, N. Van Osselaer, A. Haelens et al., “Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties,” Biochemistry, vol. 36, no. 9, pp. 2716–2723, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Van Damme, A. Wuyts, G. Froyen et al., “Granulocyte chemotactic protein-2 and related CXC chemokines: from gene regulation to receptor usage,” Journal of Leukocyte Biology, vol. 62, no. 5, pp. 563–569, 1997. View at Google Scholar · View at Scopus
  21. L. C. Parker, L. R. Prince, and I. Sabroe, “Translational mini-review series on Toll-like receptors: networks regulated by Toll-like receptors mediate innate and adaptive immunity,” Clinical and Experimental Immunology, vol. 147, no. 2, pp. 199–207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Yoshimura, K. Matsushima, J. J. Oppenheim, and E. J. Leonard, “Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1),” Journal of Immunology, vol. 139, no. 3, pp. 788–793, 1987. View at Google Scholar · View at Scopus
  23. A. Iezzi, C. Ferri, A. Mezzetti, and F. Cipollone, “COX-2: friend or foe?” Current Pharmaceutical Design, vol. 13, no. 16, pp. 1715–1721, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. K. S. Doran, G. Y. Liu, and V. Nizet, “Group B streptococcal β-hemolysin/cytolysin activates neutrophil signaling pathways in brain endothelium and contributes to development of meningitis,” Journal of Clinical Investigation, vol. 112, no. 5, pp. 736–744, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. P. F. Dijkers, K. U. Birkenkamp, E. W. F. Lam et al., “FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity,” Journal of Cell Biology, vol. 156, no. 3, pp. 531–542, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Shinjyo, R. Kuribara, T. Inukai et al., “Downregulation of Bim, a proapoptotic relative of Bcl-2, is a pivotal step in cytokine-initiated survival signaling in murine hematopoietic progenitors,” Molecular and Cellular Biology, vol. 21, no. 3, pp. 854–864, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. M. W. Smith, J. E. Schmidt, J. E. Rehg, C. J. Orihuela, and J. A. McCullers, “Induction of pro- and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenza,” Comparative Medicine, vol. 57, no. 1, pp. 82–89, 2007. View at Google Scholar · View at Scopus
  28. M. P. Soares, M. P. Seldon, I. P. Gregoire et al., “Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation,” Journal of Immunology, vol. 172, no. 6, pp. 3553–3563, 2004. View at Google Scholar · View at Scopus
  29. M. P. Soares, A. Usheva, S. Brouard et al., “Modulation of endothelial cell apoptosis by heme oxygenase-1-derived carbon monoxide,” Antioxidants and Redox Signaling, vol. 4, no. 2, pp. 321–329, 2002. View at Google Scholar · View at Scopus
  30. C. Siauw, A. Kobsar, C. Dornieden et al., “Group N streptococcus isolates from septic patients and healthy carriers differentially activate platelet signaling cascades,” Thrombosis and Haemostasis, vol. 95, no. 5, pp. 836–849, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. M. D. Maines, Heme Oxygenase: Clinical Applications and Functions, CRC Press, Boca Raton, Fla, USA, 1st edition, 1992.
  32. G. R. Gourley, “Bilirubin metabolism and kernicterus,” Advances in Pediatrics, vol. 44, pp. 173–229, 1997. View at Google Scholar · View at Scopus
  33. C. D. Ferris, S. R. Jaffrey, A. Sawa et al., “Haem oxygenase-1 prevents cell death by regulating cellular iron,” Nature Cell Biology, vol. 1, no. 3, pp. 152–157, 1999. View at Google Scholar · View at Scopus
  34. S. Brouard, P. O. Berberat, E. Tobiasch, M. P. Seldon, F. H. Bach, and M. P. Soares, “Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-κB to protect endothelial cells from tumor necrosis factor-α-mediated apoptosis,” Journal of Biological Chemistry, vol. 277, no. 20, pp. 17950–17961, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. U. P. Singh, S. Singh, P. N. Boyaka, J. R. McGhee, and J. W. Lillard, “Granulocyte chemotactic protein-2 mediates adaptive immunity in part through IL-8Rβ interactions,” Journal of Leukocyte Biology, vol. 76, no. 6, pp. 1240–1247, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. C. G. Maloney, S. D. Thompson, H. R. Hill, J. F. Bohnsack, T. M. McIntyre, and G. A. Zimmerman, “Induction of cyclooxygenase-2 by human monocytes exposed to group B streptococci,” Journal of Leukocyte Biology, vol. 67, no. 5, pp. 615–621, 2000. View at Google Scholar · View at Scopus
  37. G. E. Caughey, L. G. Cleland, P. S. Penglis, J. R. Gamble, and M. J. James, “Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2,” Journal of Immunology, vol. 167, no. 5, pp. 2831–2838, 2001. View at Google Scholar · View at Scopus
  38. T. Suzuki, S. I. Hashimoto, N. Toyoda et al., “Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE,” Blood, vol. 96, no. 7, pp. 2584–2591, 2000. View at Google Scholar · View at Scopus